London

HSBC Continental Europe: Pre Stabilisation Notice

Retrieved on: 
Thursday, November 2, 2023
London, Sale, United Kingdom, Financial Conduct Authority, Financial services, Issuer, RNS, London Stock Exchange, Person, State, Exercise, Prospectus, Financial Services and Markets Act 2000, EEA, Finance, Investment, Greenshoe, Security (finance), EU

However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time.

Key Points: 
  • However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time.
  • Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.
  • This announcement is not an offer of securities for sale into the United States.
  • RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.

Shell announces commencement of a share buyback programme

Retrieved on: 
Thursday, November 2, 2023
London, Euronext Amsterdam, Shell plc, Shell, London Stock Exchange, Annual general meeting, Withdrawal, European Union (Withdrawal Agreement) Act 2020, United Kingdom Internal Market Act 2020, CBOE, European Union (Withdrawal) Act 2018, Share repurchase, Agreement, Article, European, BATS, Market abuse, Security (finance), Brexit, EU

Shell plc (the ‘Company’) today announces the commencement of a $3.5 billion share buyback programme covering an aggregate contract term of approximately three months (the ‘programme’).

Key Points: 
  • Shell plc (the ‘Company’) today announces the commencement of a $3.5 billion share buyback programme covering an aggregate contract term of approximately three months (the ‘programme’).
  • The purpose of the programme is to reduce the issued share capital of the Company.
  • In this announcement “Shell”, “Shell Group” and “Group” are sometimes used for convenience where references are made to Shell plc and its subsidiaries in general.
  • ‘‘Subsidiaries’’, “Shell subsidiaries” and “Shell companies” as used in this announcement refer to entities over which Shell plc either directly or indirectly has control.

CytomX Therapeutics to Present at Upcoming November Investor Conferences

Retrieved on: 
Wednesday, November 1, 2023
Conference, Therapy, London, SAN, Mobile phone, Nursing, Nightclub

SOUTH SAN FRANCISCO, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that management will participate in the following investor conferences in November.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that management will participate in the following investor conferences in November.
  • Live webcasts of the Jefferies London and Piper Sandler Healthcare Conference fireside chats will be available on the Events and Presentations page of CytomX’s website at www.cytomx.com .
  • In addition, management will be available for one-on-one meetings with investors who are registered to attend the conferences.

RS BioTherapeutics Promotes Michelle L. Shuffett, MD to Chief Medical Officer

Retrieved on: 
Tuesday, October 31, 2023
Knowledge, University, Children's Hospital Los Angeles, London, Medicine, Barts and The London School of Medicine and Dentistry, Born This Way Foundation, MD, TEC, Bureau of Oceans and International Environmental and Scientific Affairs, Organization, Health, Research, IPF, Senior, RS, Boehringer Ingelheim, Everyday Health, Idiopathic disease, UCLA Mattel Children's Hospital, NIH, Patient, Hospital, COPD, Idiopathic pulmonary fibrosis, Child, Pharmaceutical industry, Nursing, Economics

CUMBERLAND, Md., Oct. 31, 2023 (GLOBE NEWSWIRE) -- RS BioTherapeutics, whose mission is to develop life-changing medicines for the millions of people suffering from diseases characterized by pulmonary inflammation, is pleased to announce that it has appointed Michelle L. Shuffett, MD as its Chief Medical Officer.

Key Points: 
  • CUMBERLAND, Md., Oct. 31, 2023 (GLOBE NEWSWIRE) -- RS BioTherapeutics, whose mission is to develop life-changing medicines for the millions of people suffering from diseases characterized by pulmonary inflammation, is pleased to announce that it has appointed Michelle L. Shuffett, MD as its Chief Medical Officer.
  • Commenting on the promotion of Dr. Shuffett to Chief Medical Officer, Dean Hart, Chief Executive Officer of RS BioTherapeutics said, “Michelle has been a tremendous addition to our leadership team.
  • Michelle will Chair the TEC and that group will help guide the development of RSBT-001.”
    Commenting on her appointment, Dr. Shuffett said, “I’m thrilled to continue working with the incredible leadership team at RS BioTherapeutics in this new role.
  • Dr. Shuffett has also served in senior roles at several organizations including Synapse Medical Communications, Everyday Health, Columbia Care, and Radicle Science.

CoinFund Announces Appointment of Dmitry Lapidus as Senior Liquid Analyst

Retrieved on: 
Wednesday, November 1, 2023
Technology, Consulting, Banking, Accounting, Telecommunications, Professional Services, Blockchain, Internet, Cryptocurrency, Knowledge, Government, BlackRock, London School of Business and Finance, Investment, London, Growth, Fund, LSE, Economics

Today CoinFund , a leading crypto-native investment firm and registered investment adviser, announces the appointment of Hong Kong-based Dmitry Lapidus as Senior Liquid Analyst to deepen analysis of liquid opportunities globally.

Key Points: 
  • Today CoinFund , a leading crypto-native investment firm and registered investment adviser, announces the appointment of Hong Kong-based Dmitry Lapidus as Senior Liquid Analyst to deepen analysis of liquid opportunities globally.
  • This appointment further underscores the position of CoinFund’s investment team at the convergence of traditional finance and cryptonative experience, led by founder-friendly investors and technologists.
  • Dmitry brings more than a decade of experience investing and living in APAC, including in Hong Kong and Singapore.
  • Dmitry will join CoinFund’s Liquid Investment team led by Managing Partner Seth Ginns as the firm furthers its mission to champion the leaders of the new internet.

Notice of Intention to Delist From the London Stock Exchange

Retrieved on: 
Friday, October 27, 2023
Professional Services, Insurance, Human Resources, Finance, Consulting, Banking, Accounting, ISIN, GMT, London Stock Exchange, Official List, UK, Main Market, Onitsha, London, The Company, LSE, FCA, Security (finance)

The Company is therefore proposing the Cancellation of the London Listing.

Key Points: 
  • The Company is therefore proposing the Cancellation of the London Listing.
  • Pursuant to Listing Rule 5.2.8R, the Company is required to give at least 20 business days’ notice of the intended Cancellation of the London Listing.
  • Following the Cancellation of the London Listing, the Company will continue to maintain its primary listing on the New York Stock Exchange.
  • The Cancellation of the London Listing is expected to have limited impact for shareholders who hold their Shares on the New York Stock Exchange.

Mesirow Wealth Management Hires Kevin Crouch as Part of Ongoing Multi-Faceted Growth Strategy

Retrieved on: 
Wednesday, November 1, 2023
London, Barron's, London School of Economics, Commodity, Chicago Mercantile Exchange, Spirit, Bachelor of Arts, Rosenblum, Growth, Trader, Highbridge Multi-Strategy Fund, Chicago, Financial services, Northwestern University, Economics

Firm hires Kevin Crouch as Wealth Advisor, joining Rosenblum | Korach Wealth Management team

Key Points: 
  • Firm hires Kevin Crouch as Wealth Advisor, joining Rosenblum | Korach Wealth Management team
    CHICAGO, Nov. 1, 2023 /PRNewswire/ -- Mesirow, an independent, employee-owned financial services firm, today announced that Kevin Crouch has joined Mesirow as a Wealth Advisor, joining the Rosenblum | Korach Wealth Management team.
  • Kevin will focus on providing comprehensive wealth planning and constructing investment strategies tailored to fit the needs of high net worth individuals and families.
  • Attracting top Wealth Advisor talent is an integral part of our growth strategy, along with ongoing organic growth and continued momentum through potential acquisitions in the wealth management space."
  • I am excited to be joining Mesirow Wealth Management and look forward to contributing to the ongoing growth of the firm's founding capability," said Kevin Crouch .

Liabilities, Damages and other Contentious Issues in International Commercial Agreements Training Course - ResearchAndMarkets.com

Retrieved on: 
Friday, October 27, 2023
Training, Education, Tim Thorogood, Trade, SME, London, BP, University of Oxford, International business, Breaking news, ADR, OBE, London Stock Exchange, Publication, Research, HM, BA, Oxford Institute of Legal Practice, Business, University, Motorola, Queen, Oxford University Innovation, KPMG, Lawyer, FRSA, Audit committee, Practice of law, Management

He was formerly a partner and Head of Commercial Law at KPMG Legal.

Key Points: 
  • He was formerly a partner and Head of Commercial Law at KPMG Legal.
  • Arun is cited and ranked in Chambers Guide of the World's Leading Lawyers.
  • He concentrates on international investment, joint ventures, licensing of technology, research and development, M&A, energy, outsourcing and corporate governance in developed and emerging markets.
  • He was appointed an OBE by HM the Queen in January 1999 for services to international trade, investment and intercultural management.

Transaction in Own Shares

Retrieved on: 
Friday, October 27, 2023
London, United Kingdom, Council, Financial Conduct Authority, Appendix, RNS, London Stock Exchange, Treasury, MAR, European Parliament, United States securities regulation, EUR, Cryptocurrency, Nordea, EU

The repurchase of own shares is executed in public trading in accordance with Regulation No.

Key Points: 
  • The repurchase of own shares is executed in public trading in accordance with Regulation No.
  • 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052.
  • After the disclosed transactions, Nordea holds 9,131,874 treasury shares for capital optimisation purposes and 4,787,315 treasury shares for remuneration purposes.
  • Details of each transaction are included as an appendix to this announcement.

AMUNDI ETF – Important Information – Mergers on Amundi Funds – 10/11/2023

Retrieved on: 
Friday, October 27, 2023
London Stock Exchange, London, ETF, Absorption, ISA, Overview, Microsoft Excel, Security (finance)

They can also be found on Amundi website: Important information: Merger of several ETFs | Amundi ETF Luxembourg | Retail

Key Points: 
  • They can also be found on Amundi website: Important information: Merger of several ETFs | Amundi ETF Luxembourg | Retail
    The Absorbed ETFs below will merge into the Receiving ETFs on 10/11/2023.
  • The receiving tickers in green will be transferred and activated on the merger date, please find the details in the table below.
  • Tickers in green = new tickers, tickers in red = discontinued tickers.
  • Please refer to the Overview section of the Excel file attached for more information.